Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial
<br><strong>Background </strong>C-reactive protein (CRP) point-of-care testing can reduce antibiotic use in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in primary care, without compromising patient care. Further safe reductions may be possible...
Autors principals: | Gillespie, D, Butler, CC, Bates, J, Hood, K, Melbye, H, Phillips, R, Stanton, H, Alam, MF, Cals, JW, Cochrane, A, Kirby, N, Llor, C, Lowe, R, Naik, G, Riga, E, Sewell, B, Thomas-Jones, E, White, P, Francis, NA |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Royal College of General Practitioners
2021
|
Ítems similars
-
C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations
per: Butler, C, et al.
Publicat: (2019) -
Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD
per: Gillespie D, et al.
Publicat: (2022-02-01) -
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT
per: Francis, NA, et al.
Publicat: (2020) -
General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial
per: Bates, J, et al.
Publicat: (2017) -
Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD
per: Francis NA, et al.
Publicat: (2020-12-01)